The #BostonHeartWalk is next month, and #TeamLantheus is getting ready to step out in support of the American Heart Association. We’re proud to walk as #OneLantheus for those impacted by heart disease and stroke, and to help build a healthier future for all. Mark your calendar and get ready to join us. Every step we take moves us closer to stronger hearts and longer lives. Whether you're walking alongside us or cheering us on from afar, thank you for making a difference. Learn more: 2025 Boston Heart Walk: https://lnkd.in/eanFqNKK
Lantheus
Pharmaceutical Manufacturing
Bedford, Massachusetts 30,019 followers
Find. Fight. Follow.™
About us
With more than 65 years of experience in delivering life-changing science, Lantheus is committed to improving patient outcomes through diagnostics, radiotherapeutics and artificial intelligence solutions that enable clinicians to Find, Fight and Follow disease. Lantheus is headquartered in Massachusetts and has offices in Canada and Sweden.
- Website
-
http://www.lantheus.com/
External link for Lantheus
- Industry
- Pharmaceutical Manufacturing
- Company size
- 501-1,000 employees
- Headquarters
- Bedford, Massachusetts
- Type
- Public Company
- Founded
- 1956
- Specialties
- Precision diagnostics, Targeted therapeutics, Radiopharmaceutical oncology, Artificial intelligence solutions, Strategic partnerships, and Just-in-time manufacturing
Locations
-
Primary
201 Burlington Road
South Building
Bedford, Massachusetts 01730, US
-
331 Treble Cove Road
North Billerica, MA 01862, US
-
1111 boul. Dr. Frederik-Philips
Suite 100
Saint-Laurent, Québec H4M 2X6, CA
-
Scheelevägen 27
Lund, Skane County, SE
Employees at Lantheus
-
Cheryl Ball
Biopharma Transformation Leader | Strategic Growth Architect | Proven Expertise in Corporate Development and Portfolio Optimization
-
Leah Pfile, MBA
Commercialization & Marketing Leader | Executive Director
-
Jean-Claude Provost
Chief Medical Officer / Vice President / Research and Development in Pharmaceutical / Biotech / Life Sciences industry
-
Michelle Meppen
Updates
-
#TeamLantheus enjoyed connecting with experts in #cardiology at #ASE2025! We're excited to advance cardiac imaging solutions and look forward to continuing to #FindFightFollow for patients with #CVD.
-
At Lantheus, our commitment to #GoFurther for patients begins with safety. Patient safety is foundational to every solution we bring to life, from precision diagnostics to targeted radiotherapeutics. We hold ourselves to the highest standards of integrity and care on behalf of our providers, partners and patients. On #WorldPatientSafetyDay, we proudly stand with the global healthcare community to champion a shared commitment: advancing a safer, stronger and more effective healthcare system for all.
-
This #NationalHispanicHeritageMonth, Lantheus honors the strength of Hispanic and Latinx communities—and shines a light on a critical unmet need when it comes to their health. #Prostatecancer is the most commonly diagnosed cancer among Latin men, yet they are significantly less likely to receive timely, definitive treatment. At #Lantheus, we’re committed to advancing radiodiagnostic innovations to support early and accurate detection.
-
#TeamLantheus is gearing up for the 2025 International Bubble Conference starting September 10th! We’re proud to be an industry partner for this conference and look forward to connecting with providers and other experts in the field of contrast enhanced ultrasound. See the agenda: https://bit.ly/4mHBQZ4 #BUBBLEMTG2025
-
-
Don’t miss it! Our symposium at #ASE2025 starts tomorrow at 12:30 PM in Science & Technology Theater #1. Join us for a lunch symposium led by Kristen Billick, BS, ACS, RCS, RDCS (AE, PE), FASE on Enhancing Cardiac Imaging: The Role of a UEA in Cardiomyopathy Assessment. #FindFightFollow
-
We’re proud to stand with our new colleagues from Life Molecular Imaging and Alzheimer's Disease International during #WorldAlzMonth to raise awareness of this growing global health concern. Together as #OneLantheus, we are committed to furthering innovative #radiodiagnostic solutions that may make a difference for patients and families impacted by this disease. Learn more about our work in #AD and #Neurology: http://bit.ly/42c66Dc
Dementia is not a normal part of aging, yet per the Alzheimer's Disease International (ADI), there are over 55 million people around the world living with dementia. September is World Alzheimer’s Month, an international campaign to raise dementia awareness and challenge stigma. Each year, Alzheimer's disease and dementia associations, alongside all those involved in the treatment, care and support of people living with dementia, from around the world unite to organize advocacy and information provision events. LMI proudly recognizes World Alzheimer’s Month and stands with ADI in raising awareness that dementia is not a normal part of aging. As part of Lantheus, learn how we are advancing care and improving outcomes for those living with dementia and AD: https://bit.ly/4lG88Cz #FindFightFollow #AskAboutDementia #AskAboutAlzheimers #WorldAlzMonth #LMI
-
-
September is #ProstateCancerAwarenessMonth, a time to elevate conversations, drive early detection and support patients at every stage of their journey. At #Lantheus, patients are at the center of everything we do as we seek to transform the landscape of #prostatecancer care by investigating innovative radiodiagnostic and radiotherapeutic solutions. For us, it’s personal, with #TeamLantheus members like Charlie who speak out on the importance of knowing your numbers and taking action when needed. Learn more: Time2see.com
-
This #LaborDay, we recognize and celebrate the dedication, innovation and impact of our team at #Lantheus. Today, we honor the passion and purpose that drive progress in our industry and beyond. Thank you for all that you do. Wishing everyone a safe and restful holiday! #TeamLantheus
-
-
#Lantheus is heading to the American Society of Echocardiography’s 2025 Scientific Sessions on September 5th! Visit us at booth #823 to connect and enjoy a tasty treat (bubble tea!) or stop by our symposium on September 6th at 12:30 PM. We’ll be exploring the pivotal role of ultrasound enhancing agents (UEAs) in echocardiographic assessment of cardiomyopathies. Learn more: https://bit.ly/45AU2xs #ASE2025
-